Urgent.News

What's breaking now, across thousands of outlets.

World

Hanwha Solutions completes technical validation for 500kV-Class HVAC cable materials

Hanwha Solutions’ Wire & Cable division is expanding its extra-high-voltage cable materials portfolio after passing validation tests in the extra-high-voltage alternating current transmission (HVAC) segment. The company plans to diversify its global customer portfolio and broaden materials supply across a wide range of applications, including power plants, transmission networks and large-scale…

Hanwha Solutions completes technical validation for 500kV-Class HVAC cable materials

Hanwha Solutions, a leading player in the Wire & Cable division, has recently accomplished a significant milestone in the extra-high-voltage alternating current (HVAC) transmission segment. The company's dedication to expanding its extra-high-voltage cable materials portfolio has been realized through successful validation tests of its 500-kilovolt HVAC cables.

These tests, which were conducted in collaboration with Chinese cable manufacturers Qingdao Hanhe and TBEA, serve as a testament to Hanwha Solutions' commitment to delivering high-quality, reliable cable materials. These cables, featuring cross-linked polyethylene (XLPE) insulation and semiconductive materials, have met stringent evaluation criteria, including insulation performance and long-term reliability under extreme voltage transmission conditions.

The test was overseen by the Shanghai National Center of Testing and Inspection for Electric Cable and Wire, an institution affiliated with the Shanghai Electric Cable Research Institute. This achievement not only broadens Hanwha Solutions' global customer base but also enhances the availability of diverse materials for various applications, including power plants, transmission networks, and renewable energy projects.

Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Other reports of this story

Every outlet that reported this, and when →

Read the original at koreatimes.co.kr →

More in World

German Court Overturns Keytruda SC Sales Ban, Opening Door to European Expansion

The path to market entry in Germany, Europe’s largest pharmaceutical market, has opened for Keytruda SC, the subcutaneous formulation of the immuno-oncology drug developed by U.S.-based Merck (MSD)…

  • German court overturns ban on Keytruda SC sales, allowing European expansion.
  • Merck wins patent disputes in Germany and U.S., clearing path for drug's entry.
  • Keytruda SC's subcutaneous formulation reduces treatment time to one to two minutes.

More from Friday 20 November →